EUVIMEDEUVIMED entdecken
Übersichtsarbeit

The Role of Mitochondrial Dynamics in Doxorubicin‐Induced Disease: Implications for Therapy

Huan Yue, Yousheng Chen, Junxiao Feng, Weiying Yue, Xingjuan Shi iD

Journal of Cellular Physiology · 2025

DOI: 10.1002/jcp.70064 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Journal of Cellular Physiology, 2025. Verfasst von Huan Yue und 4 weiteren Autor:innen. Beteiligte Einrichtung: School of Life Science and Technology, Key Laboratory of Developmental Genes and Human Disease, Southeast University, Nanjing, China. Hauptthemen laut MEDLINE: Mitochondrial Dynamics, Doxorubicin, Mitochondria, Antibiotics, Antineoplastic. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 107 Literaturangaben. Gefördert von: This study was supported by grants from the National Natural Science Foundation of China (82170370, 81770381)..

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

As an anthracycline chemotherapy drug, doxorubicin (Dox) is generally prescribed to treat a variety of malignant tumors. Nevertheless, Dox exhibited toxicity at a high dosage, which might eventually lead to injury of the body. Mitochondrial dynamics, including mitochondrial fission and fusion, regulates mitochondrial homeostasis and cellular function. Mounting evidence has demonstrated that imbalance in mitochondrial dynamics, manifested by increased mitochondrial fission or decreased mitochondrial fusion, is associated with the development of Dox‐induced diseases. In this paper, we will elaborate the role of mitochondrial dynamics in Dox‐induced diseases, and discuss the regulatory mechanism of mitochondrial dynamics in Dox‐induced diseases, including apoptosis, fibrosis, myocardial atrophy and inflammation. Elucidating these issues may provide important value in the diagnosis and potential therapeutic strategies for Dox‐induced diseases through regulation of mitochondria dynamics.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Mitochondrial DynamicsDoxorubicinMitochondriaAntibiotics, AntineoplasticHumansAnimalsApoptosisFibrosisInflammation

Stichwörter der Autor:innen

Dox‐induced diseasesapoptosisfibrosismitochondrial dynamicsmitochondrial fissionmitochondrial fusion

Substanzen

DoxorubicinAntibiotics, Antineoplastic

Autor:innen und Institutionen

  • School of Life Science and Technology, Key Laboratory of Developmental Genes and Human Disease, Southeast University, Nanjing, China.

ORCID-Profile: Xingjuan Shi

Förderung

  • This study was supported by grants from the National Natural Science Foundation of China (82170370, 81770381).

Zitieren

APA

Yue, H., Chen, Y., Feng, J., Yue, W., & Shi, X. (2025). The Role of Mitochondrial Dynamics in Doxorubicin‐Induced Disease: Implications for Therapy. Journal of Cellular Physiology. https://doi.org/10.1002/jcp.70064

Vancouver

Yue H, Chen Y, Feng J, Yue W, Shi X. The Role of Mitochondrial Dynamics in Doxorubicin‐Induced Disease: Implications for Therapy. Journal of Cellular Physiology. 2025. doi:10.1002/jcp.70064

BibTeX
@article{Yue2025,
  author = {Yue, Huan and Chen, Yousheng and Feng, Junxiao and Yue, Weiying and Shi, Xingjuan},
  title = {The Role of Mitochondrial Dynamics in Doxorubicin‐Induced Disease: Implications for Therapy},
  journal = {Journal of Cellular Physiology},
  year = {2025},
  doi = {10.1002/jcp.70064}
}
Kostenlos starten →